Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-31.85%
operating margin TTM
-35.95%
revenue TTM
41.85 Million
revenue per share TTM
0.67$
valuation ratios | |
|---|---|
| pe ratio | -2.50 |
| peg ratio | 0.38 |
| price to book ratio | 13.48 |
| price to sales ratio | 0.80 |
| enterprise value multiple | -1.27 |
| price fair value | 13.48 |
profitability ratios | |
|---|---|
| gross profit margin | 71.01% |
| operating profit margin | -35.95% |
| pretax profit margin | -32.93% |
| net profit margin | -31.85% |
| return on assets | -29.21% |
| return on equity | -165.13% |
| return on capital employed | -55.12% |
liquidity ratios | |
|---|---|
| current ratio | 1.09 |
| quick ratio | 0.81 |
| cash ratio | 0.30 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 151.64 |
| operating cycle | 221.81 |
| days of payables outstanding | 105.99 |
| cash conversion cycle | 115.82 |
| receivables turnover | 5.20 |
| payables turnover | 3.44 |
| inventory turnover | 2.41 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.47 |
| debt equity ratio | 8.64 |
| long term debt to capitalization | 0.84 |
| total debt to capitalization | 0.90 |
| interest coverage | -11.63 |
| cash flow to debt ratio | -0.53 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.16 |
| cash per share | 0.08 |
| operating cash flow per share | -0.16 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -0.53 |
| short term coverage ratios | -1.40 |
| capital expenditure coverage ratio | -78.85 |
Frequently Asked Questions
When was the last time Cytosorbents Corporation (NASDAQ:CTSO) reported earnings?
Cytosorbents Corporation (CTSO) published its most recent earnings results on 13-05-2026.
What is Cytosorbents Corporation's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Cytosorbents Corporation (NASDAQ:CTSO)'s trailing twelve months ROE is -165.13%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Cytosorbents Corporation (CTSO) currently has a ROA of -29.21%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CTSO's net profit margin stand at?
CTSO reported a profit margin of -31.85% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CTSO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.09 in the most recent quarter. The quick ratio stood at 0.81, with a Debt/Eq ratio of 8.64.